Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News

Pledge the Gift of Life

Each year, the lives of thousands of people across the country are saved because someone made the choice to become an organ donor. In April, Allegheny Health Network is honored to celebrate National Donate Life Month and pay tribute to all of those who have bestowed the precious gift of life to another through organ donation. Visit AHNdonate.org to learn more and register to be an organ donor.



Format: 04/20/2014
Format: 04/20/2014


Allegheny General Hospital Radiation Oncologists Showcase Talent, Innovative Therapies at National Conference

Friday, November 6th, 2009

PITTSBURGH - Allegheny General Hospital’s expertise and leadership in radiation oncology came into the national spotlight this week as AGH cancer specialists detailed a number of groundbreaking treatments and new cancer-fighting technologies at the annual meeting of the American Society for Radiation Oncology (ASTRO). 

AGH radiation oncologists made 12 scientific presentations at this meeting and the associated Adaptive Radiation Therapy (ART) Forum and the ARTISTE User Meeting, Oct. 31-Nov.5 in Chicago.

Among the presentations and abstracts delivered by the AGH team at ASTRO included emerging treatments for liver and breast cancer, AGH’s electronic medical records system - one of the most advanced radiation oncology EMR systems in the world - and AGH’s experience with kView, a highly advanced image-guided radiation therapy that AGH was first in the world to test.

“As an international leader in radiation oncology, AGH and the West Penn Allegheny Health System Radiation Oncology Network offer a unique blend of personalized, multi-disciplinary patient care and state-of-the-art treatment capabilities available at few other centers,” said David S. Parda, MD, Chairman of the West Penn Allegheny Health System Radiation Oncology Network. “For us to make 12 presentations during the past week at the major U.S. radiation oncology meeting is further evidence of our department’s significant and growing influence in the radiation oncology field.”

Dr. Parda served as a faculty member and organizer at ASTRO, the most important radiation oncology conference in the U.S. and one of the most important worldwide. It is an educational meeting where expertise and treatment advances for cancer patients are shared by national and international experts.

Earlier this year, AGH was named one of the nation’s “Top Radiation Therapy Centers to Watch in 2009” by Imaging Technology News. The magazine lauded AGH’s Department of Radiation Oncology for its investment in state-of-the-art technology, operational efficiency, exceptional patient care services and status as an influential market leader in cancer treatment.

At the ARTISTE user meeting, Dr. Parda discussed AGH's first experience with ARTISTE and In-Line kView, the most advanced radiation delivery and imaging device manufactured to date, helping doctors verify patient positioning before treatment and providing excellent three-dimensional soft-tissue contrast. AGH is the first in the world to investigate kView under an IRB approved protocol.

AGH is also the first site worldwide to integrate the Siemens Artiste Linear Accelerator with BrainLab, a sophisticated cranial and full body radiosurgery technology that provides physicians with enhanced capabilities in the treatment of brain tumors and other benign and malignant diseases throughout the body, and vision RT, an infrared system allowing monitoring of patient motion during treatment.

AGH is one of a few sites nationwide offering patients Accelerated Partial Breast Irradiation (APBI), a technique that makes it possible for women who undergo a lumpectomy and radiation, then suffer a cancer recurrence, to again undergo radiation treatment, sparing them a mastectomy. Mark G. Trombetta, MD, WPAHS Director of Clinical Program Development, Breast Cancer and Brachytherapy at AGH’s Department of Radiation Oncology, spoke on APBI at the Adaptive Radiation Therapy Forum.

Also at the ART Forum, Alexander V. Kirichenko, MD, PhD, WPAHS Director of Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) spoke on AGH’s pioneering use of SRS and SRT as a treatment for liver cancer. SRS/SRT greatly decreases the amount of time patients must spend in treatment - accomplishing in 1-2 weeks (one to five radiation treatments) what used to take 5-7 weeks (25-35 radiation treatments) – while also improving survival outcomes.

Other AGH physicians gave presentations on adaptive and image-guided radiation therapy, head and neck cancer, prostate cancer, ocular melanoma, electronic medical records and other advanced technologies. They included Thomas B. Julian, MD; Stephen M. Karlovits, MD; Russell Fuhrer, MD, Ralph Miller Jr., MD, and Thierry C. Verstraeten, MD.

AGH is the flagship facility in West Penn Allegheny’s network of nine radiation oncology clinics in western Pennsylvania and eastern Ohio, representing one of the nation’s most comprehensive and technologically advanced radiation oncology programs. More than 300 patients each day receive care at one of the WPAHS Radiation Oncology Network sites.



West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)

Did you find what you were looking for?

Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 7 + 5 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.